When President Trump entered his first term, stocks were steadily marching upward. This time, the trajectory has inverted.
Terns Pharmaceuticals is a small-cap biotech with a couple of weight loss candidates in its pipeline. The stock's price target on Wall Street implies significant upside potential. The drugmaker's ...
The 4% drop in the Nasdaq on Monday marked its worst day in years as Trump refused to rule out recession.
The stock is down by 49% from its peak of $72.98 last week. The chart: Why: Hims & Hers said ... out commercially available doses of its weight-loss drug, the company said it would still offer ...
According to Bloomberg, Musk's net worth has dropped by $103 billion in the year to date, reflecting a 23.8 percent decrease ...
On Wall Street, Hewlett Packard Enterprises slumped 16.2% after reporting profit for the latest quarter that fell just short of analysts' expectations. CEO Antonio Neri acknowledged that “we could ...